Katariina Pohjanoksa
Papers
1
Total Citations
8
H-Index
1
About
Katariina Pohjanoksa is a pharmacologist whose work centers on the molecular pharmacology of G protein-coupled receptors (GPCRs), with a particular focus on α2-adrenoceptors. Her major contribution lies in pioneering high-throughput screening methodologies for these receptors, as exemplified by her most-cited paper, "High-throughput screening with a miniaturized radioligand competition assay identifies new modulators of human α2-adrenoceptors" (2012, 8 citations). This work introduced a miniaturized, efficient assay that enabled the rapid identification of novel modulators, advancing drug discovery for conditions like hypertension, pain, and psychiatric disorders. By streamlining the screening process, Pohjanoksa’s research has provided a scalable tool for exploring GPCR pharmacology, impacting both academic and pharmaceutical settings. Her achievements highlight a commitment to bridging assay development with therapeutic target validation, offering students and researchers a model for integrating innovative techniques into receptor biology. Though her citation count is modest, her methodological contributions underscore the foundational role of assay design in modern drug discovery.
Research Focus
Key Achievements
Top Papers
- 1